References
- Elmore, S. (2007) Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35, 495-516. https://doi.org/10.1080/01926230701320337
- Hwang, I. T., Chung, Y. M., Kim, J. J., Chung, J. S., Kim, B. S., Kim, H. J., Kim, J. S. and Yoo, Y. D. (2007) Drug resistance to 5-FU linked to reactive oxygen species modulator 1. Biochem. Biophys. Res. Commun. 359, 304-310. https://doi.org/10.1016/j.bbrc.2007.05.088
- Jones, D. V., Jr., Winn, R. J., Brown, B. W., Levy, L. B., Pugh, R. P., Wade, J. L., 3rd, Gross, H. M., Pendergrass, K. B., Levin, B. and Abbruzzese, J. L. (1995) Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer. Cancer 76, 1709-1714. https://doi.org/10.1002/1097-0142(19951115)76:10<1709::AID-CNCR2820761006>3.0.CO;2-5
- Kang, K. A., Piao, M. J., Kim, K. C., Kang, H. K., Chang, W. Y., Park, I. C., Keum, Y. S., Surh, Y. J. and Hyun, J. W. (2014) Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation. Cell Death Dis. 5, e1183. https://doi.org/10.1038/cddis.2014.149
- Kantari, C. and Walczak, H. (2011) Caspase-8 and bid: caught in the act between death receptors and mitochondria. Biochim. Biophys. Acta 1813, 558-563. https://doi.org/10.1016/j.bbamcr.2011.01.026
- Longley, D. B., Harkin, D. P. and Johnston, P. G. (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 3, 330-338. https://doi.org/10.1038/nrc1074
- McIlwain, D. R., Berger, T. and Mak, T. W. (2015) Caspase functions in cell death and disease. Cold Spring Harb. Perspect. Biol. 7, a026716. https://doi.org/10.1101/cshperspect.a026716
- Pinedo, H. M. and Peters, G. F. (1988) Fluorouracil: biochemistry and pharmacology. J. Clin. Oncol. 6, 1653-1664. https://doi.org/10.1200/JCO.1988.6.10.1653
- Schieber, M. and Chandel, N. S. (2014) ROS function in redox signaling and oxidative stress. Curr. Biol. 24, R453-R462. https://doi.org/10.1016/j.cub.2014.03.034
- Siegel, R., Naishadham, D. and Jemal, A. (2012) Cancer statistics, 2012. CA Cancer J. Clin. 62, 10-29. https://doi.org/10.3322/caac.20138
- Singh, N. P. (2000) Microgels for estimation of DNA strand breaks, DNA protein crosslinks and apoptosis. Mutat. Res. 455, 111-127. https://doi.org/10.1016/S0027-5107(00)00075-0
- Sinha, V. R. and Honey (2012) Critical aspects in rationale design of fluorouracil-based adjuvant therapies for the management of colon cancer. Crit. Rev. Ther. Drug Carrier. Syst. 29, 89-148. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v29.i2.10
- Wohlhueter, R. M., McIvor, R. S. and Plagemann, P. G. (1980) Facilitated transport of uracil and 5-fluorouracil, and permeation of orotic acid into cultured mammalian cells. J. Cell. Physiol. 104, 309-319. https://doi.org/10.1002/jcp.1041040305
Cited by
- Bioactivity and pharmacological properties of α-mangostin from the mangosteen fruit: a review vol.28, pp.5, 2018, https://doi.org/10.1080/13543776.2018.1455829
- The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells vol.9, pp.1, 2019, https://doi.org/10.1038/s41598-018-36808-z
- α-Mangostin Synergizes the Antineoplastic Effects of 5-Fluorouracil Allowing a Significant Dose Reduction in Breast Cancer Cells vol.9, pp.3, 2016, https://doi.org/10.3390/pr9030458
- Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment vol.10, pp.9, 2021, https://doi.org/10.3390/biology10090854